Flagship Harbor Advisors, LLC Amicus Therapeutics, Inc. Transaction History

Flagship Harbor Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$13.47 - $24.89 $2,694 - $4,978	-200 Closed	0 $0
Q3 2020 Oct 13, 2020	SELL	$12.89 - $15.89 $4,266 - $5,259	-331 Reduced 62.34%	200 $2,000
Q2 2020 Jul 31, 2020	BUY	$8.86 - $15.69 $2,932 - $5,193	331 Added 165.5%	531 $8,000
Q2 2018 Aug 14, 2018	BUY	$13.13 - $17.09 $2,626 - $3,418	200 New	200 $3,000

312

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.75B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.